Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte®
PRESS RELEASES

HOME | NEWS / EVENTS | Press Releases

LABCYTE PRESS RELEASES

LABCYTE
PRESS RELEASES

JUL 31, 2012
The Institute of Cancer Research Selects the Labcyte Access™ Laboratory Workstation for Enhancing its Drug Discovery Capabilities

Labcyte has announced that The Institute of Cancer Research (ICR) has implemented its Access workstation to automate the production of low-volume, assay-ready microplates from high-throughput screening and fragment libraries for biochemical, cell-based, and biophysical screening.

JUN 19, 2012
Cancer Research Technology Selects the Labcyte Access™ Laboratory Workstation to Prepare Assay-Ready Microplates for Cell-Based Screening

Cancer Research Technology (CRT), the cancer-focused technology development and commercialization arm of Cancer Research UK, announced today the implementation of the Labcyte Access workstation to automate the production of assay-ready plates to be used in a high-throughput cell based screening program.

MAY 22, 2012
Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market

The Echo® liquid handler that leverages the company’s core acoustic technology is set to revolutionize liquid handling.

FEB 06, 2012
Labcyte Advances Automatic Acoustic Liquid Handling With Dynamic Fluid Analysis™

Labcyte has patented and released a novel software algorithm that enables a greater range of fluid types to be automatically transferred with acoustic energy. Dynamic Fluid Analysis enables the Echo® liquid handling systems to adapt to fluid properties changes such as surface tension and viscosity, and adjusts sound energy in real time with no operator intervention required. The advanced capabi...

JAN 24, 2012
QIAGEN to Provide siRNA Libraries in Labcyte Acoustically Compatible Microplates

Labcyte Inc., the developer of acoustic liquid handling, and QIAGEN, the leading global provider of sample and assay technologies, announced today that QIAGEN FlexiPlate siRNA reagent libraries are now available in Labcyte Echo® qualified microplates. These microplates enable researchers to use the Echo® liquid handler to miniaturize the transfer of small interfering RNA reagents.




MAIN CONTACT
LABCYTE INC.
170 Rose Orchard Way
San Jose, California 95134
USA
Tel:
+1 408 747-2000
Toll-free:
+1 877 742-6548
Sales:
+1 877 742-6548, option 1
Fax:
+1 408 747-2010
Contact:
REQUEST INFO

PRESS CONTACT
Nicole Litchfield
Bioscribe, Inc.
Tel:
+1 415 793-6468
Email:
nicole@bioscribe.com
TOP